Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation

被引：8

作者：

Yue WenTao ^{[1
]}

Zhao XiaoTing ^{[1
]}

Zhang LiNa ^{[1
]}

Liu ZhiDong ^{[2
]}

Ma Li ^{[1
]}

Jia WenYun ^{[1
]}

Qian Zhe ^{[1
]}

Zhang ChunYan ^{[1
]}

Wang Yue ^{[1
]}

Yang XueHui ^{[1
]}

Xu ShaoFa ^{[2
]}

机构：

[1] Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing 101149, Peoples R China

[2] Capital Med Univ, Beijing Chest Hosp, Dept Thorac Surg, Beijing 101149, Peoples R China

来源：

SCIENCE CHINA-LIFE SCIENCES | 2010年 / 53卷 / 04期

关键词：

CCNY; NSCLC; lentivirus RNAi; H1299; EXPRESSION; A1;

D O I：

10.1007/s11427-010-0090-8

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Cyclin Y (CCNY) is a key cell cycle regulator that acts as a growth factor sensor to integrate extracellular signals with the cell cycle machinery. The expression status of CCNY in lung cancer and its clinical significance remain unknown. The data indicates that CCNY may be deregulated in non-small cell lung cancer, where it may act to promote cell proliferation. These studies suggest that CCNY may be a candidate biomarker of NSCLC and a possible therapeutic target for lung cancer treatment.

引用

页码：511 / 516

页数：6

共 50 条

[31] Carvacrol Targets AXL to Inhibit Cell Proliferation and Migration in Non-small Cell Lung Cancer Cells
Jung, Chi Young
Kim, So-Young
Lee, Chuhee
ANTICANCER RESEARCH, 2018, 38 (01) : 279 - 286
[32] The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer
Li, Yan
Miao, Liyun
Cai, Hourong
Ding, Jingjing
Xiao, Yonglong
Yang, Jun
Zhang, Deping
ONCOLOGY LETTERS, 2013, 6 (06) : 1565 - 1572
[33] FIGNL1 promotes non-small cell lung cancer cell proliferation
Li, Miao
Rui, Yan
Peng, Wenjia
Hu, Junfeng
Jiang, Anbang
Yang, Zeyu
Huang, Linian
INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (01) : 83 - 99
[34] Long non-coding RNAs associated with non-small cell lung cancer
Zhan, Yuting
Zang, Hongjing
Feng, Juan
Lu, Junmi
Chen, Lingjiao
Fan, Songqing
ONCOTARGET, 2017, 8 (40) : 69174 - 69184
[35] Prognostic significance of RelB overexpression in non-small cell lung cancer patients
Qin, Hualong
Zhou, Jun
Zhou, Peng
Xu, Jingjing
Tang, Zaixiang
Ma, Haitao
Guo, Feng
THORACIC CANCER, 2016, 7 (04) : 415 - 421
[36] Amplification and Overexpression of MET in Brain Metastases of Non-Small Cell Lung Cancer
Akyurek, N.
Ercan, C.
Ekinci, O.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1040 - S1040
[37] CD44 promotes cell proliferation in non-small cell lung cancer
Hu, Bo
Ma, Yuanyuan
Yang, Yue
Zhang, Lijian
Han, Haibo
Chen, Jinfeng
ONCOLOGY LETTERS, 2018, 15 (04) : 5627 - 5633
[38] Overexpression of Ulk2 inhibits proliferation and enhances chemosensitivity to cisplatin in non-small cell lung cancer
Cheng, Hong
Yang, Ze-Tian
Bai, Yu-Quan
Cai, Yan-Fei
Zhao, Jin-Ping
ONCOLOGY LETTERS, 2019, 17 (01) : 79 - 86
[39] Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study
Liu, Bing
Wan, Zhaohui
Sheng, Baowei
Lin, Yong
Fu, Tian
Zeng, Qingdi
Qi, Congcong
BMC PULMONARY MEDICINE, 2017, 17
[40] Treatment of non-small cell lung cancer
Reinmuth, N.
Heigener, D.
Reck, M.
INTERNIST, 2011, 52 (12): : 1414 - 1421

← 1 2 3 4 5 →